+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In-Vitro Fertilization Market Strategic Research Report

  • PDF Icon

    Report

  • 178 Pages
  • July 2026
  • Region: Global
  • Navadhi
  • ID: 6286002
Global demand for in-vitro fertilization services and supporting technologies has transitioned from a niche clinical segment into a structurally resilient, high-growth healthcare category. The market was worth USD 24.08 billion in 2025 and is expected to grow at a CAGR of 9.6% to reach USD 41.7 billion by 2031, driven by rising infertility prevalence, delayed family formation, expanding insurance coverage for fertility treatment, and continued clinical success-rate improvements.

Scope of Global In-Vitro Fertilization Market Strategic Research Report 2026-2031

  • This report provides forecast data by value for the global IVF market, with 2025 as the base year and forecasting to 2031.
  • This report provides segmentation by service/product type (Fresh IVF Cycles, Frozen IVF Cycles, Donor Cycles, Reagents & Media, Equipment) and by end-user.
  • This report provides region-wise and country-level forecast data.
  • This report identifies key growth drivers and inhibitors affecting the global IVF market.
  • This report provides company profiles for key fertility clinic networks and technology providers.
  • This report provides Porter's Five Forces, PESTLE, and SWOT analysis.
  • This report identifies key future trends through 2031.

Who can use the Global In-Vitro Fertilization Market Research Report?

This research report is ideal for people who wish to understand this market. Some of the intended users are:
  • C-level executives and Company Directors in fertility clinic networks and reproductive health companies
  • Investment managers and Healthcare private equity analysts
  • Anyone operating in the IVF value chain.

Table of Contents

1. Executive Summary
2. Industry Overview & Forecast
3. Market Segmentation by Type
4. Market Segmentation by Application
5. Regional Market Forecast
6. Country-Level Market Forecast
7. Growth Drivers & Inhibitors
8. Key Company Profiles
9. Competitive Landscape
10. Porter's Five Forces Analysis
11. PESTLE Analysis
12. SWOT Analysis
13. Future Trends & Outlook

Companies Mentioned

  • Vitrolife AB
  • CooperSurgical (Cooper Companies)
  • Merck KGaA (Fertility Division)
  • IGENOMIX (Eurofins Group)
  • Ferring Pharmaceuticals
  • Gedeon Richter
  • Origio (Hamilton Thorne)
  • IVI-RMA Global
  • Care Fertility Group
  • Monash IVF Group
  • Virtus Health
  • Progyny Inc.
  • Genea
  • Reproductive Medicine Associates (RMA)
  • Fujifilm Irvine Scientific
  • Cook Medical (Fertility Division)
  • Nidacon International
  • Gynetics Medical Products